Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee
Completed
Flexion Therapeutics, Inc.
Phase 2
2014-04-01
The purpose of this study was to assess the magnitude and duration of pain relief of a single
IA injection of 2 doses (16 and 32 mg) of FX006, an extended-release formulation of TCA,
relative to normal saline (placebo control).
Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee
Terminated
Flexion Therapeutics, Inc.
Phase 2
2015-02-01
This study was a double-blind, randomized, parallel group, proof of concept study comparing
FX006 to Kenalog®-40 (triamcinolone acetonide injectable suspension, USP) in patients with
post-traumatic osteoarthritis of the knee.
Study to Characterize the PK and Local Extent and Duration of Exposure From FX006 in Patients With OA of the Knee
Completed
Flexion Therapeutics, Inc.
Phase 2
2015-11-01
The objectives of this study were to characterize the local extent and duration of exposure
of TA from FX006 and TCA IR, characterize the systemic PK of FX006 and TCA IR, and assess the
safety and general tolerability of a single 5 mL IA injection of 32 mg FX006 relative to 40
mg of TCA IR in patients with OA of the knee.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
